{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:58:08Z","timestamp":1792825088335,"version":"4.5.0"},"reference-count":174,"publisher":"BMJ","issue":"11","funder":[{"DOI":"10.13039\/501100004795","name":"Institut Universitaire de France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008398","name":"Internationale Stichting Alzheimer Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008398","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000364","name":"Stroke Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer\u2019s Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009003","name":"Hotchkiss Brain Institute, University of Calgary","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1136\/jnnp-2016-314697","type":"journal-article","created":{"date-parts":[[2017,8,26]],"date-time":"2017-08-26T20:20:15Z","timestamp":1503778815000},"page":"982-994","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":225,"title":["The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice"],"prefix":"10.1136","volume":"88","author":[{"given":"Gargi","family":"Banerjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Carare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Cordonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric E","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark van","family":"Buchem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen van der","family":"Grond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel M","family":"Verbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Werring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,8,26]]},"reference":[{"key":"key-10.1136\/jnnp-2016-314697-1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1474-4422(10)70104-6","article-title":"Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges","volume":"9","author":"Pantoni","year":"2010","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/archneur.63.1.148","article-title":"Cerebral amyloid angiopathy and lobar intracerebral hemorrhage","volume":"63","author":"Smith","year":"2006","journal-title":"Arch Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/jnnp-2011-301308","article-title":"Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum","volume":"83","author":"Charidimou","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2016-314697-4","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/jnnp-2015-310690","article-title":"Mapping the landscape of cerebral amyloid angiopathy research: an informetric analysis perspective","volume":"87","author":"Charidimou","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2016-314697-5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(12)70015-7","article-title":"Amyloid-related imaging abnormalities in patients with Alzheimer\u2019s disease treated with bapineuzumab: a retrospective analysis","volume":"11","author":"Sperling","year":"2012","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-6","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1212\/WNL.56.4.537","article-title":"Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria","volume":"56","author":"Knudsen","year":"2001","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314697-7","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1212\/WNL.0b013e3181dad605","article-title":"Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy","volume":"74","author":"Linn","year":"2010","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314697-8","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1126\/science.2111584","article-title":"Mutation of the Alzheimer\u2019s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type","volume":"248","author":"Levy","year":"1990","journal-title":"Science"},{"key":"key-10.1136\/jnnp-2016-314697-9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1750-3639.1996.tb00793.x","article-title":"Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D): I--A review of clinical, radiologic and genetic aspects","volume":"6","author":"Bornebroek","year":"1996","journal-title":"Brain Pathol"},{"key":"key-10.1136\/jnnp-2016-314697-10","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.nbd.2003.08.019","article-title":"Hereditary cerebral hemorrhage with amyloidosis Dutch type (AbetaPP 693): decreased plasma amyloid-beta 42 concentration","volume":"14","author":"Bornebroek","year":"2003","journal-title":"Neurobiol Dis"},{"key":"key-10.1136\/jnnp-2016-314697-11","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1212\/01.WNL.0000156946.44593.24","article-title":"Microbleeds in hereditary cerebral hemorrhage with amyloidosis-Dutch type","volume":"64","author":"van den Boom","year":"2005","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314697-12","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1161\/STROKEAHA.109.554378","article-title":"Descriptive analysis of the Boston criteria applied to a Dutch-type cerebral amyloid angiopathy population","volume":"40","author":"van Rooden","year":"2009","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2016-314697-13","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1161\/STROKEAHA.116.014418","article-title":"Early magnetic resonance imaging and cognitive markers of hereditary cerebral amyloid angiopathy","volume":"47","author":"van Rooden","year":"2016","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2016-314697-14","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S1474-4422(16)30030-8","article-title":"Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study","volume":"15","author":"Fotiadis","year":"2016","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/ana.23566","article-title":"Functional magnetic resonance imaging detection of vascular reactivity in cerebral amyloid angiopathy","volume":"72","author":"Dumas","year":"2012","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1474-4422(16)30346-5","article-title":"Cerebrovascular function in presymptomatic and symptomatic individuals with hereditary cerebral amyloid angiopathy: a case-control study","volume":"16","author":"van Opstal","year":"2017","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-17","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1212\/WNL.0000000000003181","article-title":"Recurrent hemorrhage risk and mortality in hereditary and sporadic cerebral amyloid angiopathy","volume":"87","author":"van Etten","year":"2016","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314697-18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1212\/WNL.0000000000003486","article-title":"\u03b2-Amyloid in CSF: biomarker for preclinical cerebral amyloid angiopathy","volume":"88","author":"van Etten","year":"2017","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314697-19","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/jnnp-2012-304434","article-title":"Enlarged perivascular spaces as a marker of underlying arteriopathy in intracerebral haemorrhage: a multicentre MRI cohort study","volume":"84","author":"Charidimou","year":"2013","journal-title":"J Neurol Neurosurg Psychiat"},{"key":"key-10.1136\/jnnp-2016-314697-20","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1161\/STROKEAHA.114.005568","article-title":"White matter perivascular spaces are related to cortical superficial siderosis in cerebral amyloid angiopathy","volume":"45","author":"Charidimou","year":"2014","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2016-314697-21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1212\/01.wnl.0000438225.02729.04","article-title":"White matter perivascular spaces: an MRI marker in pathology-proven cerebral amyloid angiopathy?","volume":"82","author":"Charidimou","year":"2014","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314697-22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jns.2016.05.040","article-title":"Clinical features of high-degree centrum semiovale-perivascular spaces in cerebral amyloid angiopathy","volume":"367","author":"Koo","year":"2016","journal-title":"J Neurol Sci"},{"key":"key-10.1136\/jnnp-2016-314697-23","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1161\/STROKEAHA.115.009090","article-title":"White matter perivascular spaces on magnetic resonance imaging: marker of cerebrovascular amyloid burden?","volume":"46","author":"Charidimou","year":"2015","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2016-314697-24","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/ijs.12054","article-title":"Enlarged perivascular spaces and cerebral small vessel disease","volume":"10","author":"Potter","year":"2015","journal-title":"Int J Stroke"},{"key":"key-10.1136\/jnnp-2016-314697-25","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1212\/01.wnl.0000435291.49598.54","article-title":"Neurovascular decoupling is associated with severity of cerebral amyloid angiopathy","volume":"81","author":"Peca","year":"2013","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314697-26","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.nicl.2016.02.020","article-title":"Longitudinal decrease in blood oxygenation level dependent response in cerebral amyloid angiopathy","volume":"11","author":"Switzer","year":"2016","journal-title":"Neuroimage Clin"},{"key":"key-10.1136\/jnnp-2016-314697-27","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1212\/WNL.0b013e31826043a9","article-title":"Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy","volume":"79","author":"Gurol","year":"2012","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314697-28","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/jcbfm.2014.43","article-title":"Diagnostic utility of amyloid PET in cerebral amyloid angiopathy-related symptomatic intracerebral hemorrhage","volume":"34","author":"Baron","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"key":"key-10.1136\/jnnp-2016-314697-29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139926","article-title":"Early-Phase 11C-PiB PET in amyloid angiopathy-related symptomatic cerebral hemorrhage: potential diagnostic value?","volume":"10","author":"Farid","year":"2015","journal-title":"PLoS One"},{"key":"key-10.1136\/jnnp-2016-314697-30","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1212\/WNL.0000000000003197","article-title":"Florbetapir-PET to diagnose cerebral amyloid angiopathy: a prospective study","volume":"87","author":"Gurol","year":"2016","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314697-31","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1474-4422(14)70003-1","article-title":"Outcome markers for clinical trials in cerebral amyloid angiopathy","volume":"13","author":"Greenberg","year":"2014","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-32","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1007\/s00415-015-7736-1","article-title":"Clinical spectrum, underlying etiologies and radiological characteristics of cortical superficial siderosis","volume":"262","author":"Lummel","year":"2015","journal-title":"J Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-33","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00415-012-6610-7","article-title":"Superficial siderosis is a warning sign for future intracranial hemorrhage","volume":"260","author":"Linn","year":"2013","journal-title":"J Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-34","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1212\/01.wnl.0000435298.80023.7a","article-title":"Cortical superficial siderosis and intracerebral hemorrhage risk in cerebral amyloid angiopathy","volume":"81","author":"Charidimou","year":"2013","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314697-35","article-title":"Convexity subarachnoid haemorrhage has a high risk of intracerebral haemorrhage in suspected cerebral amyloid angiopathy","volume":"264","author":"Wilson","year":"2017","journal-title":"J Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-36","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/WNL.0000000000003281","article-title":"Cortical superficial siderosis predicts early recurrent lobar hemorrhage","volume":"87","author":"Roongpiboonsopit","year":"2016","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314697-37","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1212\/WNL.0000000000001288","article-title":"Cortical superficial siderosis: a marker of vascular amyloid in patients with cognitive impairment","volume":"84","author":"Na","year":"2015","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314697-38","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1212\/WNL.0000000000000150","article-title":"Prevalence of cortical superficial siderosis in a memory clinic population","volume":"82","author":"Zonneveld","year":"2014","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314697-39","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00415-013-7181-y","article-title":"Prevalence of cortical superficial siderosis in patients with cognitive impairment","volume":"261","author":"Wollenweber","year":"2014","journal-title":"J Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3174\/ajnr.A4496","article-title":"Diagnostic significance of cortical superficial siderosis for Alzheimer Disease in patients with cognitive impairment","volume":"37","author":"Inoue","year":"2016","journal-title":"Am J Neuroradiol"},{"key":"key-10.1136\/jnnp-2016-314697-41","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.0000000000003088","article-title":"Cortical superficial siderosis: prevalence and biomarker profile in a memory clinic population","volume":"87","author":"Shams","year":"2016","journal-title":"Neurology"},{"issue":"3-4","key":"key-10.1136\/jnnp-2016-314697-42","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000442299","article-title":"Cortical superficial siderosis in memory clinic patients: further evidence for underlying cerebral amyloid agiopathy","volume":"41","author":"Charidimou","year":"2016","journal-title":"Cerebrovasc Dis"},{"key":"key-10.1136\/jnnp-2016-314697-43","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1212\/WNL.0b013e3181ae7c5e","article-title":"Superficial siderosis in the general population","volume":"73","author":"Vernooij","year":"2009","journal-title":"Neurology"},{"issue":"Pt 8","key":"key-10.1136\/jnnp-2016-314697-44","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1093\/brain\/awv162","article-title":"Cortical superficial siderosis: detection and clinical significance in cerebral amyloid angiopathy and related conditions","volume":"138","author":"Charidimou","year":"2015","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2016-314697-45","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S1474-4422(16)00130-7","article-title":"Dementia risk after spontaneous intracerebral haemorrhage: a prospective cohort study","volume":"15","author":"Moulin","year":"2016","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-46","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.jalz.2015.04.009","article-title":"Diagnostic value of lobar microbleeds in individuals without intracerebral hemorrhage","volume":"11","author":"Martinez-Ramirez","year":"2015","journal-title":"Alzheimers Dement"},{"key":"key-10.1136\/jnnp-2016-314697-47","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jalz.2015.09.004","article-title":"Establishing the \u2019meaning' of microbleeds: clinical context or lobar microbleed burden?","volume":"12","author":"Wilson","year":"2016","journal-title":"Alzheimers Dement"},{"key":"key-10.1136\/jnnp-2016-314697-48","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/jamaneurol.2016.0832","article-title":"Total magnetic resonance\u00a0imaging burden of small vessel disease in cerebral amyloid angiopathy: an\u00a0imaging-pathologic study of concept validation","volume":"73","author":"Charidimou","year":"2016","journal-title":"JAMA Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-49","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00005072-199756070-00001","article-title":"Differences between the pathogenesis of senile plaques and congophilic angiopathy in Alzheimer disease","volume":"56","author":"Verbeek","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-50","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ana.21694","article-title":"Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy","volume":"66","author":"Verbeek","year":"2009","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-51","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1007\/s00415-012-6520-8","article-title":"Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteria","volume":"259","author":"Renard","year":"2012","journal-title":"J Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-52","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3233\/JAD-160400","article-title":"Cerebrospinal fluid Alzheimer\u2019s disease biomarkers in isolated supratentorial cortical superficial siderosis","volume":"54","author":"Renard","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"key-10.1136\/jnnp-2016-314697-53","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/ana.23857","article-title":"Anti-amyloid \u03b2 autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies","volume":"73","author":"Piazza","year":"2013","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-54","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3233\/JAD-150621","article-title":"Cerebrospinal fluid Alzheimer?s disease biomarkers in cerebral amyloid angiopathy-related inflammation","volume":"50","author":"Renard","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"key-10.1136\/jnnp-2016-314697-55","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/0271678X15606141","article-title":"Cerebrospinal fluid profiles with increasing number of cerebral microbleeds in a continuum of cognitive impairment","volume":"36","author":"Shams","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"key":"key-10.1136\/jnnp-2016-314697-56","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1161\/STROKEAHA.109.558197","article-title":"Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition","volume":"40","author":"Goos","year":"2009","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2016-314697-57","doi-asserted-by":"crossref","first-page":"1011.e1","DOI":"10.1016\/j.neurobiolaging.2011.10.026","article-title":"Microbleeds relate to altered amyloid-\u03b2 metabolism in Alzheimer\u2019s disease","volume":"33","author":"Goos","year":"2012","journal-title":"Neurobiol Aging"},{"key":"key-10.1136\/jnnp-2016-314697-58","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/jamaneurol.2014.754","article-title":"Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers","volume":"71","author":"Kester","year":"2014","journal-title":"JAMA Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-59","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3233\/JAD-160651","article-title":"Cerebral amyloid angiopathy-related microbleeds and cerebrospinal fluid biomarkers in Alzheimer\u2019s disease","volume":"55","author":"Noguchi-Shinohara","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"key-10.1136\/jnnp-2016-314697-60","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1212\/01.wnl.0000191403.95453.6a","article-title":"Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy","volume":"66","author":"Gurol","year":"2006","journal-title":"Neurology"},{"issue":"1-4","key":"key-10.1136\/jnnp-2016-314697-61","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000333811","article-title":"Plasma \u03b2-amyloid levels in cerebral amyloid angiopathy-associated hemorrhagic stroke","volume":"10","author":"Hernandez-Guillamon","year":"2012","journal-title":"Neurodegener Dis"},{"key":"key-10.1136\/jnnp-2016-314697-62","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1750-3639.2008.00133.x","article-title":"Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer\u2019s disease","volume":"18","author":"Weller","year":"2008","journal-title":"Brain Pathol"},{"key":"key-10.1136\/jnnp-2016-314697-63","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.bbadis.2015.08.024","article-title":"Deposition of amyloid \u03b2 in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy","volume":"1862","author":"Keable","year":"2016","journal-title":"Biochimica Biophysica Acta"},{"key":"key-10.1136\/jnnp-2016-314697-64","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2990.2007.00926.x","article-title":"Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology","volume":"34","author":"Carare","year":"2008","journal-title":"Neuropathol Appl Neurobiol"},{"key":"key-10.1136\/jnnp-2016-314697-65","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00401-011-0801-7","article-title":"Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy","volume":"121","author":"Hawkes","year":"2011","journal-title":"Acta Neuropathol"},{"key":"key-10.1136\/jnnp-2016-314697-66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041636","article-title":"Disruption of arterial perivascular drainage of amyloid-\u03b2 from the brains of mice expressing the human APOE \u03b54 allele","volume":"7","author":"Hawkes","year":"2012","journal-title":"PLoS One"},{"key":"key-10.1136\/jnnp-2016-314697-67","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2015.00136","article-title":"Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer\u2019s disease: the role, regulation and restoration of LRP1","volume":"7","author":"Ramanathan","year":"2015","journal-title":"Front Aging Neurosci"},{"key":"key-10.1136\/jnnp-2016-314697-68","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/acel.12045","article-title":"Regional differences in the morphological and functional effects of aging on cerebral basement membranes and perivascular drainage of amyloid-\u03b2 from the mouse brain","volume":"12","author":"Hawkes","year":"2013","journal-title":"Aging Cell"},{"key":"key-10.1136\/jnnp-2016-314697-69","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-11-111","article-title":"Human APOE4 increases microglia reactivity at A\u03b2 plaques in a mouse model of a\u03b2 deposition","volume":"11","author":"Rodriguez","year":"2014","journal-title":"J Neuroinflammation"},{"key":"key-10.1136\/jnnp-2016-314697-70","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2353\/ajpath.2007.070105","article-title":"Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy","volume":"171","author":"Farris","year":"2007","journal-title":"Am J Pathol"},{"key":"key-10.1136\/jnnp-2016-314697-71","doi-asserted-by":"crossref","first-page":"E1807","DOI":"10.1073\/pnas.1220484110","article-title":"ApoE influences amyloid-\u03b2 (A\u03b2) clearance despite minimal apoE\/A\u03b2 association in physiological conditions","volume":"110","author":"Verghese","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.1136\/jnnp-2016-314697-72","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1073\/pnas.0805453106","article-title":"Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy","volume":"106","author":"Hawkes","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.1136\/jnnp-2016-314697-73","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.arcmed.2014.10.010","article-title":"Cerebral ABC transporter-common mechanisms may modulate neurodegenerative diseases and depression in elderly subjects","volume":"45","author":"Pahnke","year":"2014","journal-title":"Arch Med Res"},{"key":"key-10.1136\/jnnp-2016-314697-74","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.nbd.2014.04.001","article-title":"Alzheimer\u2019s and ABC transporters \u2013 new opportunities for diagnostics and treatment","volume":"72","author":"Pahnke","year":"2014","journal-title":"Neurobiol Dis"},{"key":"key-10.1136\/jnnp-2016-314697-75","doi-asserted-by":"crossref","first-page":"11862","DOI":"10.1523\/JNEUROSCI.1001-15.2015","article-title":"Bexarotene-activated retinoid X receptors regulate neuronal differentiation and dendritic complexity","volume":"35","author":"Mounier","year":"2015","journal-title":"J Neurosci"},{"key":"key-10.1136\/jnnp-2016-314697-76","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nrneurol.2016.36","article-title":"Clearance systems in the brain \u2013 implications for Alzheimer diseaser","volume":"12","author":"Tarasoff-Conway","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-77","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0006-8993(85)91383-6","article-title":"Evidence for a \u2019paravascular' fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space","volume":"326","author":"Rennels","year":"1985","journal-title":"Brain Res"},{"key":"key-10.1136\/jnnp-2016-314697-78","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003748","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2","volume":"4","author":"Iliff","year":"2012","journal-title":"Sci Transl Med"},{"key":"key-10.1136\/jnnp-2016-314697-79","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00401-016-1555-z","article-title":"Vascular basement membranes as pathways for the passage of fluid into and out of the brain","volume":"131","author":"Morris","year":"2016","journal-title":"Acta Neuropathol"},{"key":"key-10.1136\/jnnp-2016-314697-80","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10571-015-0273-8","article-title":"Lymphatic clearance of the brain: perivascular, paravascular and significance for neurodegenerative diseases","volume":"36","author":"Bakker","year":"2016","journal-title":"Cell Mol Neurobiol"},{"key":"key-10.1136\/jnnp-2016-314697-81","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00401-016-1606-5","article-title":"Vascular, glial, and lymphatic immune gateways of the central nervous system","volume":"132","author":"Engelhardt","year":"2016","journal-title":"Acta Neuropathol"},{"key":"key-10.1136\/jnnp-2016-314697-82","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3233\/JAD-160122","article-title":"Amyloid-related Imaging abnormalities (ARIA) in immunotherapy trials for Alzheimer\u2019s disease: need for prognostic biomarkers?","volume":"52","author":"Piazza","year":"2016","journal-title":"J\u00a0Alzheimers Dis"},{"key":"key-10.1136\/jnnp-2016-314697-83","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"key-10.1136\/jnnp-2016-314697-84","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2015.00207","article-title":"Anti-A\u03b2 autoantibodies in amyloid related imaging abnormalities (ARIA): candidate biomarker for immunotherapy in Alzheimer\u2019s disease and cerebral amyloid angiopathy","volume":"6","author":"DiFrancesco","year":"2015","journal-title":"Front Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-85","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00401-014-1340-9","article-title":"A\u03b2 immunotherapy for Alzheimer\u2019s disease: effects on apoE and cerebral vasculopathy","volume":"128","author":"Sakai","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"Pt 12","key":"key-10.1136\/jnnp-2016-314697-86","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1093\/brain\/awn261","article-title":"Consequence of A\u03b2\u00a0immunization on the vasculature of human Alzheimer\u2019s disease brain","volume":"131","author":"Boche","year":"2008","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2016-314697-87","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00401-016-1635-0","article-title":"Reduced vascular amyloid burden at Microhemorrhage sites in cerebral amyloid angiopathy","volume":"133","author":"van Veluw","year":"2017","journal-title":"Acta Neuropathol"},{"key":"key-10.1136\/jnnp-2016-314697-88","first-page":"106","article-title":"Amyloid-related imaging abnormalities-haemosiderin (ARIA-H) in patients with Alzheimer\u2019s disease treated with bapineuzumab: a historical, prospective secondary analysis","volume":"87","author":"Arrighi","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2016-314697-89","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1212\/WNL.0000000000002175","article-title":"Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons","volume":"85","author":"Boyle","year":"2015","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314697-90","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ana.22112","article-title":"Cerebral amyloid angiopathy pathology and cognitive domains in older persons","volume":"69","author":"Arvanitakis","year":"2011","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-91","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(00)03589-3","article-title":"Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS)","volume":"357","author":"Neuropathology Group","year":"2001","journal-title":"Lancet"},{"key":"key-10.1136\/jnnp-2016-314697-92","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1212\/WNL.58.11.1629","article-title":"Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study","volume":"58","author":"Pfeifer","year":"2002","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314697-93","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1161\/STROKEAHA.116.012999","article-title":"Cerebral amyloid angiopathy is\u00a0associated with\u00a0executive dysfunction and mild cognitive impairment","volume":"47","author":"Case","year":"2016","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2016-314697-94","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3233\/JAD-150890","article-title":"Cognitive profile and its association with neuroimaging markers of non-demented cerebral amyloid angiopathy patients in a stroke unit","volume":"52","author":"Xiong","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"key-10.1136\/jnnp-2016-314697-95","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1159\/000336237","article-title":"Cerebral microbleeds and long-term cognitive outcome: longitudinal cohort study of stroke clinic patients","volume":"33","author":"Gregoire","year":"2012","journal-title":"Cerebrovasc Dis"},{"key":"key-10.1136\/jnnp-2016-314697-96","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1161\/STROKEAHA.116.014166","article-title":"Strictly lobar cerebral microbleeds are associated with cognitive impairment","volume":"47","author":"Chung","year":"2016","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2016-314697-97","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1093\/brain\/awq246","article-title":"What are the causes of pre-existing dementia in patients with intracerebral haemorrhages?","volume":"133","author":"Cordonnier","year":"2010","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2016-314697-98","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jamaneurol.2016.0955","article-title":"Risk factors associated with early vs delayed\u00a0dementia after\u00a0intracerebral hemorrhage","volume":"73","author":"Biffi","year":"2016","journal-title":"JAMA Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-99","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1161\/01.STR.0000143224.36527.44","article-title":"Amyloid angiopathy-related vascular cognitive impairment","volume":"35","author":"Greenberg","year":"2004","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2016-314697-100","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1212\/01.WNL.0000142966.22886.20","article-title":"White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage","volume":"63","author":"Smith","year":"2004","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314697-101","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1212\/WNL.0000000000000579","article-title":"Microinfarct disruption of white matter structure: a longitudinal diffusion tensor analysis","volume":"83","author":"Auriel","year":"2014","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314697-102","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/jcbfm.2015.88","article-title":"Ischemic brain injury in cerebral amyloid angiopathy","volume":"36","author":"Reijmer","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"issue":"Pt 1","key":"key-10.1136\/jnnp-2016-314697-103","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/brain\/awu316","article-title":"Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy","volume":"138","author":"Reijmer","year":"2015","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2016-314697-104","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1161\/STROKEAHA.116.014337","article-title":"Progression of brain network alterations in cerebral amyloid angiopathy","volume":"47","author":"Reijmer","year":"2016","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2016-314697-105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.brainres.2013.04.052","article-title":"Cerebral amyloidal angiopathy \u2013 a disease with implications for neurology and psychiatry","volume":"1519","author":"Gahr","year":"2013","journal-title":"Brain Res"},{"key":"key-10.1136\/jnnp-2016-314697-106","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1177\/0004867414525843","article-title":"Cerebral amyloid angiopathy presenting with neuropsychiatric symptoms","volume":"48","author":"Gleason","year":"2014","journal-title":"Aust N Z J Psychiatry"},{"key":"key-10.1136\/jnnp-2016-314697-107","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/ana.24647","article-title":"White matter hyperintensities are a core feature of alzheimer\u2019s disease: evidence from the dominantly inherited Alzheimer network","volume":"79","author":"Lee","year":"2016","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-108","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1212\/WNL.0000000000000732","article-title":"Posterior white matter disease distribution as a predictor of amyloid angiopathy","volume":"83","author":"Thanprasertsuk","year":"2014","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314697-109","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3233\/JAD-150274","article-title":"Cerebral amyloid angiopathy-related microbleeds correlate with glucose metabolism and brain volume in Alzheimer\u2019s disease","volume":"48","author":"Samuraki","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"key-10.1136\/jnnp-2016-314697-110","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1212\/WNL.0000000000001398","article-title":"Cerebral amyloid angiopathy with and without hemorrhage: evidence for different disease phenotypes","volume":"84","author":"Charidimou","year":"2015","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314697-111","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1016\/j.neurobiolaging.2015.08.008","article-title":"APOE and cerebral amyloid angiopathy in community-dwelling older persons","volume":"36","author":"Yu","year":"2015","journal-title":"Neurobiol Aging"},{"key":"key-10.1136\/jnnp-2016-314697-112","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/jnnp-2013-306485","article-title":"APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis","volume":"85","author":"Rannikm\u00e4e","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2016-314697-113","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1161\/STROKEAHA.112.657759","article-title":"Spectrum of transient focal neurological episodes in cerebral amyloid angiopathy: multicentre magnetic resonance imaging cohort study and meta-analysis","volume":"43","author":"Charidimou","year":"2012","journal-title":"Stroke"},{"issue":"5-6","key":"key-10.1136\/jnnp-2016-314697-114","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000381223","article-title":"The characteristics of superficial siderosis and convexity subarachnoid hemorrhage and clinical relevance in suspected cerebral amyloid angiopathy","volume":"39","author":"Ni","year":"2015","journal-title":"Cerebrovasc Dis"},{"key":"key-10.1136\/jnnp-2016-314697-115","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.11.010","article-title":"Acute convexity subarachnoid hemorrhage related to cerebral amyloid angiopathy: clinicoradiological features and outcome","volume":"25","author":"Calviere","year":"2016","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"key-10.1136\/jnnp-2016-314697-116","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000353676","article-title":"Focal cortical subarachnoid hemorrhage revealed by recurrent paresthesias: a clinico-radiological syndrome strongly associated with cerebral amyloid angiopathy","volume":"36","author":"Apoil","year":"2013","journal-title":"Cerebrovasc Dis"},{"key":"key-10.1136\/jnnp-2016-314697-117","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/ana.21943","article-title":"Recurrent spreading depolarizations after subarachnoid hemorrhage decreases oxygen availability in human cerebral cortex","volume":"67","author":"Bosche","year":"2010","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-118","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/archneurol.2010.226","article-title":"Spreading depolarization: a possible new culprit in the delayed cerebral ischemia of subarachnoid hemorrhage","volume":"68","author":"Leng","year":"2011","journal-title":"Arch Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-119","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/ene.12139","article-title":"The role of spreading depolarization in subarachnoid hemorrhage","volume":"20","author":"S\u00e1nchez-Porras","year":"2013","journal-title":"Eur J Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-120","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1212\/01.wnl.0000194267.09060.77","article-title":"Antiplatelet use after intracerebral hemorrhage","volume":"66","author":"Viswanathan","year":"2006","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314697-121","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/jnnp-2013-306476","article-title":"Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis","volume":"85","author":"Poon","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2016-314697-122","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1001\/archneur.65.10.1313","article-title":"Restarting anticoagulation therapy after warfarin-associated intracerebral hemorrhage","volume":"65","author":"Claassen","year":"2008","journal-title":"Arch Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-123","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1161\/STROKEAHA.110.593087","article-title":"Optimal timing of resumption of warfarin after intracranial hemorrhage","volume":"41","author":"Majeed","year":"2010","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2016-314697-124","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cjca.2011.10.002","article-title":"Reinitiation of anticoagulation after warfarin-associated intracranial hemorrhage and mortality risk: the best practice for reinitiating anticoagulation therapy after intracranial bleeding (BRAIN) study","volume":"28","author":"Yung","year":"2012","journal-title":"Can J Cardiol"},{"key":"key-10.1136\/jnnp-2016-314697-125","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1212\/WNL.0000000000000245","article-title":"Recurrence of ICH after resumption of anticoagulation with VK antagonists: chirone study","volume":"82","author":"Poli","year":"2014","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314697-126","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/CIRCULATIONAHA.115.015735","article-title":"Restarting anticoagulant treatment after intracranial hemorrhage in patients with\u00a0atrial fibrillation and the impact on recurrent stroke, mortality, and bleeding: a nationwide cohort study","volume":"132","author":"Nielsen","year":"2015","journal-title":"Circulation"},{"key":"key-10.1136\/jnnp-2016-314697-127","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/STROKEAHA.116.014643","article-title":"Optimal timing of anticoagulant treatment after intracerebral hemorrhage in patients with\u00a0atrial fibrillation","volume":"48","author":"Pennlert","year":"2017","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2016-314697-128","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1001\/jamainternmed.2016.9369","article-title":"Outcomes associated with resuming\u00a0warfarin treatment after hemorrhagic stroke or traumatic intracranial hemorrhage in patients with\u00a0atrial fibrillation","volume":"177","author":"Nielsen","year":"2017","journal-title":"JAMA Intern Med"},{"key":"key-10.1136\/jnnp-2016-314697-129","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/STROKEAHA.116.016327","article-title":"Restarting anticoagulant therapy after intracranial hemorrhage: a systematic review and meta-Analysis","volume":"48","author":"Murthy","year":"2017","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2016-314697-130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijcard.2015.05.159","article-title":"Statins and the risk of dementia in patients with atrial fibrillation: a nationwide population-based cohort study","volume":"196","author":"Chao","year":"2015","journal-title":"Int J Cardiol"},{"key":"key-10.1136\/jnnp-2016-314697-131","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/jama.2015.0846","article-title":"Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage","volume":"313","author":"Kuramatsu","year":"2015","journal-title":"JAMA"},{"key":"key-10.1136\/jnnp-2016-314697-132","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/STROKEAHA.114.007953","article-title":"Influence of intracerebral hemorrhage Location on incidence, characteristics, and outcome: population-based study","volume":"46","author":"Samarasekera","year":"2015","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2016-314697-133","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/STR.0000000000000069","article-title":"Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"46","author":"Hemphill","year":"2015","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2016-314697-134","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/ejcts\/ezw313","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"50","author":"Kirchhof","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"key-10.1136\/jnnp-2016-314697-135","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"key-10.1136\/jnnp-2016-314697-136","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"key-10.1136\/jnnp-2016-314697-137","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ahj.2016.03.019","article-title":"Effect of apixaban on brain infarction and microbleeds: averroes-MRI assessment study","volume":"178","author":"O\u2019Donnell","year":"2016","journal-title":"Am Heart J"},{"key":"key-10.1136\/jnnp-2016-314697-138","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-015-0898-4","article-title":"Apixaban versus antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with atrial fibrillation (APACHE-AF): study protocol for a randomised controlled trial","volume":"16","author":"van Nieuwenhuizen","year":"2015","journal-title":"Trials"},{"key":"key-10.1136\/jnnp-2016-314697-139","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2014.00003","article-title":"Use of MRI for risk stratification in anticoagulation decision making in atrial fibrillation: promising, but more data are needed for a robust algorithm","volume":"5","author":"Wilson","year":"2014","journal-title":"Front Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-140","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/CIRCULATIONAHA.115.016261","article-title":"Cerebral microbleeds are associated with an increased risk of stroke: the\u00a0rotterdam study","volume":"132","author":"Akoudad","year":"2015","journal-title":"Circulation"},{"key":"key-10.1136\/jnnp-2016-314697-141","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1212\/WNL.0000000000003183","article-title":"Recurrent stroke risk and cerebral microbleed burden in ischemic stroke and TIA: a meta-analysis","volume":"87","author":"Wilson","year":"2016","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314697-142","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1161\/STR.0000000000000116","article-title":"Prevention of stroke in patients with silent cerebrovascular disease: a scientific statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"48","author":"Smith","year":"2017","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2016-314697-143","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1161\/STROKEAHA.108.523159","article-title":"Patient-specific decision-making for warfarin therapy in nonvalvular atrial fibrillation: how will screening with genetics and imaging help?","volume":"39","author":"Eckman","year":"2008","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2016-314697-144","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/ijs.12569","article-title":"The clinical relevance of microbleeds in stroke study (CROMIS-2): rationale, design, and methods","volume":"10","author":"Charidimou","year":"2015","journal-title":"Int J Stroke"},{"key":"key-10.1136\/jnnp-2016-314697-145","first-page":"1113","article-title":"The Lancet","volume":"15","author":"Worldwide collaboration in the Microbleeds International Collaborative Network","year":"2016","journal-title":"Neurology"},{"issue":"24 Pt 2","key":"key-10.1136\/jnnp-2016-314697-146","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1212\/01.wnl.0000296277.63350.77","article-title":"Hemorrhagic stroke in the stroke prevention by aggressive reduction in cholesterol levels study","volume":"70","author":"Goldstein","year":"2008","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314697-147","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa061894","article-title":"High-dose atorvastatin after stroke or transient ischemic attack","volume":"355","author":"Amarenco","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.1136\/jnnp-2016-314697-148","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","author":"Heart Protection Study Collaborative Group","year":"2002","journal-title":"Lancet"},{"key":"key-10.1136\/jnnp-2016-314697-149","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1161\/STROKEAHA.107.488791","article-title":"Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease","volume":"39","author":"Vergouwen","year":"2008","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2016-314697-150","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1212\/WNL.0000000000002618","article-title":"Statins and poststroke intracerebral hemorrhage: concern but increasing reassurance","volume":"86","author":"Goldstein","year":"2016","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314697-151","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11883-015-0526-5","article-title":"Statins in intracerebral hemorrhage","volume":"17","author":"Lauer","year":"2015","journal-title":"Curr Atheroscler Rep"},{"key":"key-10.1136\/jnnp-2016-314697-152","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1001\/jamaneurol.2014.2124","article-title":"Effect of statin use during hospitalization for intracerebral hemorrhage on mortality and discharge disposition","volume":"71","author":"Flint","year":"2014","journal-title":"JAMA Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-153","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.06.036","article-title":"Meta-analysis of statin use for the acute therapy of spontaneous intracerebral hemorrhage","volume":"24","author":"Tapia P\u00e9rez","year":"2015","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"key-10.1136\/jnnp-2016-314697-154","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/ijs.12624","article-title":"Statin use in spontaneous intracerebral hemorrhage: a systematic review and meta-analysis","volume":"10","author":"Jung","year":"2015","journal-title":"Int J Stroke"},{"key":"key-10.1136\/jnnp-2016-314697-155","doi-asserted-by":"crossref","first-page":"e541","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.06.015","article-title":"Long-term improvement in outcome after intracerebral hemorrhage in patients treated with statins","volume":"22","author":"Winkler","year":"2013","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"key-10.1136\/jnnp-2016-314697-156","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/cns.12274","article-title":"Use of statin during hospitalization improves the outcome after intracerebral hemorrhage","volume":"20","author":"Pan","year":"2014","journal-title":"CNS Neurosci Ther"},{"key":"key-10.1136\/jnnp-2016-314697-157","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/ene.12649","article-title":"Early statin therapy in patients with acute intracerebral hemorrhage without prior statin use","volume":"22","author":"Chen","year":"2015","journal-title":"Eur J Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-158","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/ane.12143","article-title":"Impact of early statin therapy in patients with ischemic stroke or transient ischemic attack","volume":"129","author":"Chen","year":"2014","journal-title":"Acta Neurol Scand"},{"key":"key-10.1136\/jnnp-2016-314697-159","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1161\/STROKEAHA.111.645978","article-title":"Association of statins and statin discontinuation with poor outcome and survival after intracerebral hemorrhage","volume":"43","author":"Dowlatshahi","year":"2012","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2016-314697-160","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1161\/STROKEAHA.113.001304","article-title":"Apolipoprotein E, statins, and risk of intracerebral hemorrhage","volume":"44","author":"Woo","year":"2013","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2016-314697-161","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/jnnp-2015-312736","article-title":"Serum cholesterol levels, HMG-CoA reductase inhibitors and the risk of intracerebral haemorrhage. The Multicenter Study on cerebral haemorrhage in Italy (MUCH-Italy)","volume":"87","author":"Pezzini","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2016-314697-162","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/archneurol.2010.356","article-title":"Statin use following intracerebral hemorrhage: a decision analysis","volume":"68","author":"Westover","year":"2011","journal-title":"Arch Neurol"},{"key":"key-10.1136\/jnnp-2016-314697-163","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1161\/STROKEAHA.112.657486","article-title":"Statin use and microbleeds in patients with spontaneous intracerebral hemorrhage","volume":"43","author":"Haussen","year":"2012","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2016-314697-164","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1161\/STROKEAHA.114.004130","article-title":"Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study","volume":"45","author":"Romero","year":"2014","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2016-314697-165","unstructured":"A phase 2, Randomized, Double Blind Placebo Controlled Trial to evaluate the safety, tolerability, Pharmacokinetics and Efficacy of Pf-04360365 (Ponezumab) In adult subjects with Probable Cerebral Amyloid Angiopathy. http:\/\/clinicaltrials.gov\/show\/NCT01821118 (accessed 4 Sep 2016)."},{"issue":"4-5","key":"key-10.1136\/jnnp-2016-314697-166","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jmb.2011.11.047","article-title":"Structural basis of C-terminal \u03b2-amyloid peptide binding by the antibody ponezumab for the treatment of Alzheimer\u2019s disease","volume":"421","author":"La Porte","year":"2012","journal-title":"J Mol Biol"},{"key":"key-10.1136\/jnnp-2016-314697-167","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/WNF.0b013e318279bcfa","article-title":"Safety and pharmacology of ponezumab (PF-04360365) after a single 10-minute intravenous infusion in subjects with mild to moderate Alzheimer disease","volume":"36","author":"Burstein","year":"2013","journal-title":"Clin Neuropharmacol"},{"key":"key-10.1136\/jnnp-2016-314697-168","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/WNF.0b013e31827db49b","article-title":"Safety and pharmacology of a single intravenous dose of ponezumab in subjects with mild-to-moderate Alzheimer disease: a phase I, randomized, placebo-controlled, double-blind, dose-escalation study","volume":"36","author":"Landen","year":"2013","journal-title":"Clin Neuropharmacol"},{"issue":"Pt 2","key":"key-10.1136\/jnnp-2016-314697-169","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/brain\/awv313","article-title":"Passive immunotherapy targeting amyloid-\u03b2 reduces cerebral amyloid angiopathy and improves vascular reactivity","volume":"139","author":"Bales","year":"2016","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2016-314697-170","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","article-title":"Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer\u2019s Association Research Roundtable Workgroup","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"key-10.1136\/jnnp-2016-314697-171","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.150202","article-title":"Pharmacological removal of serum amyloid P component from intracerebral plaques and cerebrovascular A\u03b2 amyloid deposits in vivo","volume":"6","author":"Al-Shawi","year":"2016","journal-title":"Open Biol"},{"key":"key-10.1136\/jnnp-2016-314697-172","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1161\/STROKEAHA.109.563932","article-title":"Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the progress trial","volume":"41","author":"Arima","year":"2010","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2016-314697-173","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1161\/STROKEAHA.113.002545","article-title":"Ambulatory blood pressure in patients with lacunar stroke: association with total MRI burden of cerebral small vessel disease","volume":"44","author":"Klarenbeek","year":"2013","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2016-314697-174","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/ajh\/hpu045","article-title":"Impact of ambulatory blood pressure variability on cerebral small vessel disease progression and cognitive decline in community-based elderly Japanese","volume":"27","author":"Yamaguchi","year":"2014","journal-title":"Am J Hypertens"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2016-314697","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T14:05:44Z","timestamp":1601042744000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2016-314697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,26]]},"references-count":174,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,10,9]]},"published-print":{"date-parts":[[2017,11]]}},"alternative-id":["10.1136\/jnnp-2016-314697"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2016-314697","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,26]]}}}